NHS England strikes deal on new NICE recommended lung cancer immunotherapy drug

  • Home / NHS England strikes deal on new NICE recommended lung cancer immunotherapy drug

NHS England strikes deal on new NICE recommended lung cancer immunotherapy drug

NHS chief Simon Stevens has today announced that NHS England has struck a deal with MSD, endorsed by NICE, to make the lung cancer drug pembrolizumab available for routine use on the NHS. New trial results show pembrolizumab extends life for certain adults with lung cancer for more than a year. Pembrolizumab is the first […]

About Post Author

Medical CPD & News

The Digitalis CPD trawler searches the web for all the latest news and journals.

Privacy Preference Center

Close your account?

Your account will be closed and all data will be permanently deleted and cannot be recovered. Are you sure?

Are you sure?

By disagreeing you will no longer have access to our site and will be logged out.